43 related articles for article (PubMed ID: 35298396)
1. Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding.
Adriaenssens A; Broichhagen J; de Bray A; Ast J; Hasib A; Jones B; Tomas A; Burgos NF; Woodward O; Lewis J; O'Flaherty E; El K; Cui C; Harada N; Inagaki N; Campbell J; Brierley D; Hodson DJ; Samms R; Gribble F; Reimann F
JCI Insight; 2023 May; 8(10):. PubMed ID: 37212283
[TBL] [Abstract][Full Text] [Related]
2. Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine.
Matrone A; Gambale C; Prete A; Elisei R
Front Endocrinol (Lausanne); 2022; 13():864253. PubMed ID: 35422765
[TBL] [Abstract][Full Text] [Related]
3. Gastric Inhibitory Polypeptide Receptor (GIPR) Overexpression Reduces the Tumorigenic Potential of Retinoblastoma Cells.
Haase A; Alefeld E; Yalinci F; Meenen DV; Busch MA; Dünker N
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730608
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical GH increase after oral glucose load in subjects with and without acromegaly.
Ceccato F; Vedolin CK; Voltan G; Antonelli G; Barbot M; Basso D; Regazzo D; Scaroni C; Occhi G
J Endocrinol Invest; 2024 Jan; 47(1):213-221. PubMed ID: 37344722
[TBL] [Abstract][Full Text] [Related]
5. The Methylation Analysis of the
Dalle Nogare M; D'Annunzio S; Vazza G; Regazzo D; Picello L; Denaro L; Voltan G; Scaroni C; Ceccato F; Occhi G
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298217
[TBL] [Abstract][Full Text] [Related]
6. Genetically proxied impaired GIPR signaling and risk of 6 cancers.
Rogers M; Gill D; Ahlqvist E; Robinson T; Mariosa D; Johansson M; Cortez Cardoso Penha R; Dossus L; Gunter MJ; Moreno V; Davey Smith G; Martin RM; Yarmolinsky J
iScience; 2023 Jun; 26(6):106848. PubMed ID: 37250804
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma.
Weng D; He L; Chen X; Lin H; Ji D; Lu S; Ao L; Wang S
Front Immunol; 2022; 13():1055412. PubMed ID: 36713370
[TBL] [Abstract][Full Text] [Related]
8. Tirzepatide-Friend or Foe in Diabetic Cancer Patients?
Samuel SM; Varghese E; Kubatka P; Büsselberg D
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358930
[TBL] [Abstract][Full Text] [Related]
9. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
[TBL] [Abstract][Full Text] [Related]
10. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular biology of the GIP receptor.
Greenwell AA; Chahade JJ; Ussher JR
Peptides; 2020 Mar; 125():170228. PubMed ID: 31812593
[TBL] [Abstract][Full Text] [Related]
12. The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings.
Regazzo D; Bertazza L; Galletta E; Barollo S; Mondin A; Zovato S; Iacobone M; Zilio E; Scaroni C; Radu CM; di Benedetto G; Mian C; Lefkimmiatis K; Occhi G
Endocr Relat Cancer; 2022 Apr; 29(5):273-284. PubMed ID: 35298396
[TBL] [Abstract][Full Text] [Related]
13. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
[TBL] [Abstract][Full Text] [Related]
14. The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of
Regazzo D; Losa M; Albiger NM; Terreni MR; Vazza G; Ceccato F; Emanuelli E; Denaro L; Scaroni C; Occhi G
Eur J Endocrinol; 2017 May; 176(5):543-553. PubMed ID: 28179449
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]